The phase II OT-101 clinical trial will study a promising treatment option for patients with pleural mesothelioma.

The effects of COVID-19 on the American workforce show that workplaces are still unsafe. Some occupations contracted the virus in high rates.

A new cancer treatment (known as monoclonal antibodies) is helping COVID-19 patients with underlying conditions avoid hospitalization.